NYSE - Nasdaq Real Time Price USD
Evolent Health, Inc. (EVH)
8.34
+0.77
+(10.17%)
As of 2:24:58 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 11 | 10 | 11 |
| Avg. Estimate | 0.09 | 0.1 | 0.38 | 0.59 |
| Low Estimate | 0.01 | 0.04 | 0.21 | 0.38 |
| High Estimate | 0.16 | 0.18 | 0.59 | 0.89 |
| Year Ago EPS | 0.3 | 0.04 | 0.41 | 0.38 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 14 | 14 |
| Avg. Estimate | 459.43M | 537.7M | 2.05B | 2.39B |
| Low Estimate | 447.2M | 495.24M | 2.01B | 2.23B |
| High Estimate | 467.87M | 556.1M | 2.08B | 2.66B |
| Year Ago Sales | 647.14M | 621.4M | 2.55B | 2.05B |
| Sales Growth (year/est) | -29.01% | -13.47% | -19.58% | 16.15% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.25 | 0.34 | 0.03 | 0.1 |
| EPS Actual | 0.3 | 0.04 | -0.02 | 0.06 |
| Difference | 0.05 | -0.3 | -0.05 | -0.04 |
| Surprise % | 18.48% | -88.29% | -179.90% | -37.73% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.09 | 0.1 | 0.38 | 0.59 |
| 7 Days Ago | 0.09 | 0.1 | 0.38 | 0.59 |
| 30 Days Ago | 0.12 | 0.13 | 0.48 | 0.71 |
| 60 Days Ago | 0.12 | 0.13 | 0.47 | 0.71 |
| 90 Days Ago | 0.12 | 0.12 | 0.47 | 0.69 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 3 | 2 | 2 |
| Up Last 30 Days | 3 | 3 | 3 | 2 |
| Down Last 7 Days | 5 | 5 | 5 | 5 |
| Down Last 30 Days | 5 | 5 | 4 | 5 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| EVH | -71.30% | 138.45% | -8.30% | 56.90% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 5/13/2025 |
| Maintains | UBS: Buy to Buy | 5/9/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 4/28/2025 |
| Maintains | Truist Securities: Buy to Buy | 4/10/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 3/10/2025 |
| Maintains | Citizens Capital Markets: Market Outperform to Market Outperform | 2/24/2025 |
Related Tickers
PHR Phreesia, Inc.
25.60
+2.81%
OMCL Omnicell, Inc.
30.97
+2.55%
PRVA Privia Health Group, Inc.
22.96
+0.57%
CTEV Claritev Corporation
37.92
-0.86%
NRC National Research Corporation
14.25
+3.41%
WEAV Weave Communications, Inc.
9.59
+2.08%
SLP Simulations Plus, Inc.
28.31
+7.34%
HCAT Health Catalyst, Inc.
4.0700
+7.39%
SPOK Spok Holdings, Inc.
16.10
-0.31%
BTSGU BrightSpring Health Services, Inc.
83.65
0.00%